Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis (HIPEC)
Phase II Multicentric Exploratory Single Cohort Clinical Trial to Assess Efficacy and Safety on a New Treatment Scheme by Systemic and Peritoneal Chemotherapy Plus Cytoreduction and HIPEC Plus Adjuvant Treatment in Patients With Peritoneal Carcinomatosis From Gastric Cancer
Sponsor: Hospital General Universitario Gregorio Marañon
Suspended
unable to reach planned recruitment
This PHASE2 trial investigates Gastric Cancer and Peritoneal Carcinomatosis and is currently suspended. Hospital General Universitario Gregorio Marañon leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Suspended PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Suspended PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Suspended PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Suspended PHASE2
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital General Universitario Gregorio Marañon
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .